Multimodal Physiologic State Intelligence Study
Public ClinicalTrials.gov record NCT07814118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
OMNIPHYS: A Prospective Multimodal Longitudinal Study of AI-Enabled Physiologic State Modeling and Early Detection of Clinical Deterioration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The OMNIPHYS study will investigate whether multimodal ultrasound and other routinely collected clinical and physiologic data can be combined with artificial intelligence to characterize changes in a person's physiologic state over time. The study will examine cardiac, vascular, pulmonary, and systemic physiologic measurements and develop longitudinal models that describe baseline physiology, physiologic perturbation, compensation, deterioration, treatment response, and recovery. The study is observational and will not assign experimental treatments. The goal is to determine whether changes in multimodal physiologic patterns can be identified and characterized earlier and more reliably than conventional single-time-point assessment.
Study identification
- NCT ID
- NCT07814118
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 25,000 participants
Conditions and interventions
Conditions
- Heart Failure
- Cardiomyopathies
- Pulmonary Hypertension
- Myocarditis; Acute or Subacute
- Myocarditis Due to Drug
- Myocarditis Viral
- Pericardial Diseases
- Valvular Heart Diseases
- Hypertension
- Sepsis
- Acute Kidney Injury
- Pulmonary Edema - Acute
- Pulmonary Edema With Heart Failure
- Pulmonary Edemas
- Acute Respiratory Distress Syndrome
- Pulmonary Embolism Acute
- Pulmonary Embolism (Diagnosis)
- Pulmonary Embolism Acute Massive
- Pulmonary Embolism Subacute Massive
- Venous Thrombosis Pulmonary
- Venous Thrombosis (Disorder)
- Venous Thrombosis, Deep
- Peripheral Arterial Disease
- Peripheral Arterial Disease (PAD)
- Aortic Diseases
- Muskuloskeletal Diseases
- Brain Aging
- Brain Aneurysm
- Brain Aging Related Conditions
- Ultrasound
- Ultrasound Exams
- Ultrasound Guidance
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2026
- Primary completion
- Sep 1, 2046
- Completion
- Sep 14, 2046
- Last update posted
- Sep 9, 2026
2026 – 2046
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Truway Health, Inc. | New York | New York | 10016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07814118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2026 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07814118 live on ClinicalTrials.gov.